Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

Clinical trial NCT06633341 · RECRUITING

Trial details

NCT number: NCT06633341
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

T-lymphoblastic Lymphoma

Start date: 2024-10-20
Primary completion: 2027-10-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.